Research & Development
Showing 1 - 4 out of 4
Upfield
$25 million in build-to-suit financing for portfolio company's state-of-the-art, BREEAM Outstanding R&D facility.
Astellas
$56 million proactive repositioning of existing office into a state-of-the-art life sciences facility for new tenant.
Apotex
$468 million of sale-leaseback capital used to finance a portion of a PE firm's buyout of global pharmaceutical company.